Developer docs
API playgroundTry for free, no card

Search company profiles

Hera - Mi

Full company profile

uuid0008wlm

Namestring
Hera - Mi
Legal namestring
Hera-MI
Websiteurl
hera-mi.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Hera-MI is a French medical device software company founded in April 2017 by Sylvie Davila (CEO) and Mickael Tardy (Scientific Director), headquartered in Saint-Herblain near Nantes. The company develops Breast-SlimView, a Class IIa CE-marked (notified body KIWA 0476, since November 2019) clinical decision-support software for 2D and 3D mammography (tomosynthesis). Its patented core technology is a 'negativation' deep-learning algorithm that automatically detects and removes physiological breast elements — blood vessels, connective tissue, mammary gland, muscles, and fat — and replaces them with synthetic fat so radiologists see only suspicious areas. A second patent (2022) extends the platform into multimodality correlation across ultrasound, mammography, tomosynthesis, and MRI. The software suite also includes MTE (Mammography Technical Evaluation) for automated image-quality assessment and features breast density evaluation per BIRADS 5th edition, 3-level risk scoring, and prior-examination comparison, all delivered via DICOM-compatible integration into existing PACS infrastructure.

The company monetizes through software licensing and recurring maintenance contracts sold via direct enterprise sales (France, Belgium, Germany, Netherlands) and a network of channel partners and OEM-style integrators including Fujifilm (global), Ethicia (Switzerland/Italy), MODIMEDICARE (India), Viewtech (Mexico), and DRTECH (South Korea), with central purchasing agreements via GAIM, UGAP, and UniHA for French public-sector buyers. Customers are primarily radiologists, breast imaging specialists, and radiographers in hospitals, breast imaging centers, and radiology practices across Europe, North America (planned via Hera-MI Corp., US subsidiary established April 2020), MENA, South Asia, East Asia, and Latin America. FDA approval is in progress to unlock the US market. The company is privately held (SAS form), employs 11-50 staff, and has been commercially active since 2019 with recognized industry positioning (Prix FEMTECH Europe 2024, HUB France IA 2025 laureate).

Short descriptiontext

Hera-MI is a French medtech company that develops Breast-SlimView, a CE-marked AI clinical decision-support software for 2D and 3D mammography using a patented 'negativation' algorithm. It serves radiologists, breast imaging centers, and hospitals across Europe, with US FDA approval in progress.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint-herblain, France
HQ citystring
Saint-herblain
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI mammography software, breast cancer detection, medical imaging AI, clinical decision support, radiology software
Industry4 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code2 codes
  • Software Publishers5132
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Breast-SlimView Software Licenses
TypeSubscription Recurring
Description

Class IIa medical device software sold to radiology centers and hospitals. Installed directly into customer's center infrastructure without requiring additional hardware. Revenue likely generated through software licensing with annual maintenance and support contracts. The company is CE certified and pursuing FDA approval for US market entry.

hera-mi.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Breast-SlimView®
Description

Patented clinical decision support software for 2D and 3D mammography and tomosynthesis, designed for breast cancer diagnostic. Features include negativation process, breast density evaluation, risk scoring, and prior examination management.

hera-mi.com
+2 more records
Core offering1 text field

Hera-MI develops and licenses Breast-SlimView, a Class IIa CE-marked medical device software that provides clinical decision support for 2D and 3D mammography (tomosynthesis) interpretation. The software uses a patented 'negativation' AI algorithm that removes physiological breast elements and replaces them with artificial fat to present only suspicious areas to radiologists, complemented by image quality evaluation (MTE), breast density classification, risk scoring, and prior examination comparison. It is sold to radiology departments, breast imaging centers, and hospitals through direct enterprise sales, channel partners, and an OEM integration with Fujifilm mammography equipment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • When breast cancer is detected at an early stage, nearly 90% of cases go into remission.
+2 more records
Product overview1 text field

Hera-MI offers the Breast-SlimView Suite as a unified medical device platform for AI-powered mammography analysis. The core Breast-SlimView software provides decision support for 2D and 3D mammography using a patented 'negativation' algorithm, complemented by the MTE (Mammography Technical Evaluation) module for image quality assessment. Features include breast density evaluation based on BIRADS 5th edition, 3-level risk scoring, prior examination comparison, and structured reporting with ultrasound pictogram projection. The company is developing a multimodality correlation feature for integration across imaging modalities.

Product and service3 records
1Breast-SlimView Suite
CategoryMedical Imaging Software
Description

Comprehensive Class IIa CE-marked medical device software suite for clinical decision support in 2D and 3D mammography (tomosynthesis). Includes the patented negativation algorithm, breast density evaluation based on BIRADS 5th edition, 3-level risk scoring, prior examination comparison, structured positioning reports with ultrasound pictograms, and DICOM-compliant integration into the radiologist's standard mammography interface. Sold to radiology departments, breast imaging centers, and hospitals.

2Breast-SlimView
CategoryClinical Decision Support Software
Description

Patented decision support software dedicated to 2D and 3D mammography featuring the unique 'negativation' algorithm that detects and removes physiological breast elements and replaces them with artificial fat, displaying only relevant suspicious areas. Assists radiologists in early breast cancer detection. Installed directly into customer center infrastructure without additional hardware.

3MTE (Mammography Technical Evaluation)
CategoryImage Quality Assessment Software
Description

Image quality assessment module that automatically evaluates mammographic image quality including breast compression, positioning criteria (pectoral, nipple, inframammary fold), and technical artifacts or skin folds. Helps radiographers standardize practices, self-assess positioning, and improve diagnostic reliability.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
1ASTARTE (Association Transméditerranéenne: Femme et Cancer du Sein)
Strategic tierMinorTypeOthersAnnounced on2023-06-01
Description

Partnership officially announced at SIFEM 2023. Association fighting breast cancer inequalities in screening and treatment. Hera-MI supports awareness campaigns and helps spread messages worldwide.

hera-mi.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-03-24
Description

Partnership with network of 450 radiologists and 143 partner establishments. TéléDiag provides KeyDiag solution and expert radiologist expertise for clinical validation of Hera-MI's 2D & 3D breast imaging AI software.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-04-30
Description

Partnership for technological sharing exploration. Signed April 30, 2019 during Airbus delegation visit to Ecole Centrale Nantes. Financial support enables accelerated development through new recruitments and brings international visibility to Hera-MI.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-10-03
Description

Scientific and business partnership where Fujifilm distributes Breast-SlimView integrated into its mammography equipment. Provides radiologists with clinical decision support tool for 2D/3D mammography interpretation. Distribution in France and overseas markets. 3 workshop sessions held at JFR 2019 on Fujifilm booth.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Scientific collaboration with LS2N at Ecole Centrale de Nantes through CIFRE thesis. Mickael Tardy, Scientific Director, conducted thesis under Professor Diana Mateus. Research on AI in medical imaging.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Commercial partner hosting Hera-MI at ECR congress. Offers MedMammo multimodality diagnostic station that combines with Breast-SlimView for complete French diagnostic solution.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Swiss healthcare management company representing Hera-MI in Switzerland and Italy. Distributes and supports Breast-SlimView installations in these markets.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Association promoting French medical device manufacturers worldwide. Hera-MI featured as member for international visibility.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Strategic partnership with major player in 2D/3D mammography with global reach. Planmed mammography systems potentially integrate with Hera-MI AI.

10IDETEC MEDICAL IMAGING
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

French company specializing in manufacture and marketing of medical radiology equipment for over 40 years. Leading OEM company in Europe. THALIA mammography systems partner.

hera-mi.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

South Korean partner for AIDIA mammography system. World-renowned leader in flat panel mammography and X-ray sensors.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Mexican distributor specializing in sale, installation, and maintenance of high-tech medical equipment for radiology and mammography. Hera-MI listed on their website.

13MODIMEDICARE
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Indian company commercializing mammography and X-ray equipment. Agent representing Hera-MI mammography AI modules in India with dedicated training services.

hera-mi.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Italian company commercializing and repairing X-ray equipment. Key player based in Italy, close to customers.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

First French central purchasing agency in medical imaging. Enables public healthcare institutions to procure Breast-SlimView through established procurement channels.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Only generalist public central purchasing agency, 100% dedicated to public purchasing. Enables procurement of Hera-MI solutions by French public sector.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Cooperative of French public hospital buyers. Provides group purchasing options for Breast-SlimView by public hospitals.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnerships with French and European universities and engineering schools for research collaboration, algorithm development, and talent recruitment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with health institutions and medical imaging centers specializing in senology. Enriches data volume for software learning and provides clinical validation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

South Korea-based publicly listed AI company with Lunit INSIGHT MMG, a mammography AI solution directly comparable to Breast-SlimView in clinical decision support for breast cancer detection. Direct competitor in breast imaging AI across EU, MENA, and Asia.

TypeDirect peer
Description

French competitor specializing in MammoScreen, an AI-based mammography decision-support tool with CE mark and FDA clearance. Headquartered in France, Therapixel competes most directly with Hera-MI on geography, product, and breast imaging AI category.

TypeDirect peer
Description

New Zealand-based breast imaging analytics company offering breast density assessment, mammography reporting, and cancer risk evaluation software. Highly comparable product/clinical positioning in breast imaging AI.

TypeDirect peer
Description

Netherlands-based developer of Transpara, an AI breast imaging decision-support software for 2D/3D mammography with CE mark and FDA clearance. Direct competitor serving the same radiologist and breast center customers.

TypeDirect peer
Description

US-based company offering ProFound AI for breast cancer detection and breast density assessment (PowerDensity), both FDA-cleared. Direct competitor in mammography AI, particularly relevant for Hera-MI's pending US entry.

TypeEmerging player
Description

AI mammography company (Saige-Dx) acquired by RadNet, offering FDA-cleared AI for breast cancer detection and risk prediction. Emerging direct competitor with a strong US distribution backbone via RadNet's imaging centers.

TypeEmerging player
Description

Canada-based company focused on breast density AI and mammography quality analytics, with comparable features to Hera-MI's MTE and breast density evaluation modules. Overlaps at feature level though narrower in overall breadth.

TypeBroad incumbent
Description

US-listed leader in mammography hardware (3Dimensions, Genius AI) and integrated screening workflows. Operates broadly across breast imaging; important OEM-style incumbent that any breast AI specialist must integrate with or compete against.

TypeBroad incumbent
Description

Global medtech incumbent offering mammography systems (Mammomat) and AI-Rad Companion, with broad radiology AI portfolio. Broad incumbent providing integrating opportunities and competitive threats to specialist breast AI vendors.

TypeOthers
Description

Mammography equipment OEM that is both a channel partner and a comparable ecosystem player. Comparable in that it sits adjacent as a mammography hardware vendor with breast imaging AI integrations, including Hera-MI's Breast-SlimView.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hera - Mi

Medical Imaging Softwarehera-mi.com

Hera-MI is a French medtech company that develops Breast-SlimView, a CE-marked AI clinical decision-support software for 2D and 3D mammography using a patented 'negativation' algorithm. It serves radiologists, breast imaging centers, and hospitals across Europe, with US FDA approval in progress.

What Hera - Mi does

Hera-MI is a French medical device software company founded in April 2017 by Sylvie Davila (CEO) and Mickael Tardy (Scientific Director), headquartered in Saint-Herblain near Nantes. The company develops Breast-SlimView, a Class IIa CE-marked (notified body KIWA 0476, since November 2019) clinical decision-support software for 2D and 3D mammography (tomosynthesis). Its patented core technology is a 'negativation' deep-learning algorithm that automatically detects and removes physiological breast elements — blood vessels, connective tissue, mammary gland, muscles, and fat — and replaces them with synthetic fat so radiologists see only suspicious areas. A second patent (2022) extends the platform into multimodality correlation across ultrasound, mammography, tomosynthesis, and MRI. The software suite also includes MTE (Mammography Technical Evaluation) for automated image-quality assessment and features breast density evaluation per BIRADS 5th edition, 3-level risk scoring, and prior-examination comparison, all delivered via DICOM-compatible integration into existing PACS infrastructure.

The company monetizes through software licensing and recurring maintenance contracts sold via direct enterprise sales (France, Belgium, Germany, Netherlands) and a network of channel partners and OEM-style integrators including Fujifilm (global), Ethicia (Switzerland/Italy), MODIMEDICARE (India), Viewtech (Mexico), and DRTECH (South Korea), with central purchasing agreements via GAIM, UGAP, and UniHA for French public-sector buyers. Customers are primarily radiologists, breast imaging specialists, and radiographers in hospitals, breast imaging centers, and radiology practices across Europe, North America (planned via Hera-MI Corp., US subsidiary established April 2020), MENA, South Asia, East Asia, and Latin America. FDA approval is in progress to unlock the US market. The company is privately held (SAS form), employs 11-50 staff, and has been commercially active since 2019 with recognized industry positioning (Prix FEMTECH Europe 2024, HUB France IA 2025 laureate).

Hera - Mi firmographics

Firmographics
Name
Hera - Mi
Legal name
Hera-MI
Website
https://hera-mi.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Hera-MI is a French medtech company that develops Breast-SlimView, a CE-marked AI clinical decision-support software for 2D and 3D mammography using a patented 'negativation' algorithm. It serves radiologists, breast imaging centers, and hospitals across Europe, with US FDA approval in progress.
Ownership category
akta.pro rank

Hera - Mi industry classification

Industry
Product category
Medical Imaging Software
NAICS
Software Publishers (5132), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • AI mammography software
  • Breast cancer detection
  • Medical imaging AI
  • Clinical decision support
  • Radiology software

Where Hera - Mi is headquartered

Location

Headquarters

HQ city
Saint-herblain
HQ country
France
HQ region
Europe

Offices4 records

Markets served

Hera - Mi business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Breast-SlimView Software Licenses: Class IIa medical device software sold to radiology centers and hospitals. Installed directly into customer's center infrastructure without requiring additional hardware. Revenue likely generated through software licensing with annual maintenance and support contracts. The company is CE certified and pursuing FDA approval for US market entry.

Go-to-market motion3 records

Distribution channels9 records

Marketing channels8 records

Hera - Mi product offering

Product offering

Core offering

Hera-MI develops and licenses Breast-SlimView, a Class IIa CE-marked medical device software that provides clinical decision support for 2D and 3D mammography (tomosynthesis) interpretation. The software uses a patented 'negativation' AI algorithm that removes physiological breast elements and replaces them with artificial fat to present only suspicious areas to radiologists, complemented by image quality evaluation (MTE), breast density classification, risk scoring, and prior examination comparison. It is sold to radiology departments, breast imaging centers, and hospitals through direct enterprise sales, channel partners, and an OEM integration with Fujifilm mammography equipment.

Product overview

Hera-MI offers the Breast-SlimView Suite as a unified medical device platform for AI-powered mammography analysis. The core Breast-SlimView software provides decision support for 2D and 3D mammography using a patented 'negativation' algorithm, complemented by the MTE (Mammography Technical Evaluation) module for image quality assessment. Features include breast density evaluation based on BIRADS 5th edition, 3-level risk scoring, prior examination comparison, and structured reporting with ultrasound pictogram projection. The company is developing a multimodality correlation feature for integration across imaging modalities.

Differentiator

Problem solved

Functional benefit

Brands

  • Breast-SlimView®: Patented clinical decision support software for 2D and 3D mammography and tomosynthesis, designed for breast cancer diagnostic. Features include negativation process, breast density evaluation, risk scoring, and prior examination management.
  • Breast-SlimView® Suite
  • MTE (Mammography Technical Evaluation)

Products and services

  • Breast-SlimView Suite Comprehensive Class IIa CE-marked medical device software suite for clinical decision support in 2D and 3D mammography (tomosynthesis). Includes the patented negativation algorithm, breast density evaluation based on BIRADS 5th edition, 3-level risk scoring, prior examination comparison, structured positioning reports with ultrasound pictograms, and DICOM-compliant integration into the radiologist's standard mammography interface. Sold to radiology departments, breast imaging centers, and hospitals.
  • Breast-SlimView Patented decision support software dedicated to 2D and 3D mammography featuring the unique 'negativation' algorithm that detects and removes physiological breast elements and replaces them with artificial fat, displaying only relevant suspicious areas. Assists radiologists in early breast cancer detection. Installed directly into customer center infrastructure without additional hardware.
  • MTE (Mammography Technical Evaluation) Image quality assessment module that automatically evaluates mammographic image quality including breast compression, positioning criteria (pectoral, nipple, inframammary fold), and technical artifacts or skin folds. Helps radiographers standardize practices, self-assess positioning, and improve diagnostic reliability.

Quantifiable outcome

  • When breast cancer is detected at an early stage, nearly 90% of cases go into remission.
  • +2 more outcomes

Companies that use Hera - Mi

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Hera - Mi technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature10 records

Hera - Mi partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered minor and core.

  • ASTARTE (Association Transméditerranéenne: Femme et Cancer du Sein)minorOthers · 1 June 2023Partnership officially announced at SIFEM 2023. Association fighting breast cancer inequalities in screening and treatment. Hera-MI supports awareness campaigns and helps spread messages worldwide.
  • TéléDiagcoreStrategic or Co-development Partner · 24 March 2021Partnership with network of 450 radiologists and 143 partner establishments. TéléDiag provides KeyDiag solution and expert radiologist expertise for clinical validation of Hera-MI's 2D & 3D breast imaging AI software.
  • AirbuscoreStrategic or Co-development Partner · 30 April 2019Partnership for technological sharing exploration. Signed April 30, 2019 during Airbus delegation visit to Ecole Centrale Nantes. Financial support enables accelerated development through new recruitments and brings international visibility to Hera-MI.
  • Fujifilm FrancecoreChannel Partner/ Reseller/ Distributor · 3 October 2018Scientific and business partnership where Fujifilm distributes Breast-SlimView integrated into its mammography equipment. Provides radiologists with clinical decision support tool for 2D/3D mammography interpretation. Distribution in France and overseas markets. 3 workshop sessions held at JFR 2019 on Fujifilm booth.
  • LS2N (Laboratoire des Sciences du Numérique de Nantes)coreStrategic or Co-development PartnerScientific collaboration with LS2N at Ecole Centrale de Nantes through CIFRE thesis. Mickael Tardy, Scientific Director, conducted thesis under Professor Diana Mateus. Research on AI in medical imaging.
  • MEDECOMcoreChannel Partner/ Reseller/ DistributorCommercial partner hosting Hera-MI at ECR congress. Offers MedMammo multimodality diagnostic station that combines with Breast-SlimView for complete French diagnostic solution.
  • Ethicia Healthcare ManagementcoreChannel Partner/ Reseller/ DistributorSwiss healthcare management company representing Hera-MI in Switzerland and Italy. Distributes and supports Breast-SlimView installations in these markets.
  • French Healthcare AssociationminorGTM or Marketing PartnerAssociation promoting French medical device manufacturers worldwide. Hera-MI featured as member for international visibility.
  • PlanmedminorChannel Partner/ Reseller/ DistributorStrategic partnership with major player in 2D/3D mammography with global reach. Planmed mammography systems potentially integrate with Hera-MI AI.
  • IDETEC MEDICAL IMAGINGminorChannel Partner/ Reseller/ DistributorFrench company specializing in manufacture and marketing of medical radiology equipment for over 40 years. Leading OEM company in Europe. THALIA mammography systems partner.
  • DRTECHminorChannel Partner/ Reseller/ DistributorSouth Korean partner for AIDIA mammography system. World-renowned leader in flat panel mammography and X-ray sensors.
  • Viewtech MexicominorChannel Partner/ Reseller/ DistributorMexican distributor specializing in sale, installation, and maintenance of high-tech medical equipment for radiology and mammography. Hera-MI listed on their website.
  • MODIMEDICAREminorChannel Partner/ Reseller/ DistributorIndian company commercializing mammography and X-ray equipment. Agent representing Hera-MI mammography AI modules in India with dedicated training services.
  • URIEL SRLminorChannel Partner/ Reseller/ DistributorItalian company commercializing and repairing X-ray equipment. Key player based in Italy, close to customers.
  • GAIMminorChannel Partner/ Reseller/ DistributorFirst French central purchasing agency in medical imaging. Enables public healthcare institutions to procure Breast-SlimView through established procurement channels.
  • UGAPminorChannel Partner/ Reseller/ DistributorOnly generalist public central purchasing agency, 100% dedicated to public purchasing. Enables procurement of Hera-MI solutions by French public sector.
  • UniHAminorChannel Partner/ Reseller/ DistributorCooperative of French public hospital buyers. Provides group purchasing options for Breast-SlimView by public hospitals.
  • Academic Partners (University of Nantes, University of Rennes, Technical University of Munich, Efrei)coreStrategic or Co-development PartnerAcademic partnerships with French and European universities and engineering schools for research collaboration, algorithm development, and talent recruitment.
  • Clinical Partners (Hôpitaux universitaires de Strasbourg, Polyclinique Bordeaux Nord, IMBN, RPO, IPADE)coreStrategic or Co-development PartnerCollaboration with health institutions and medical imaging centers specializing in senology. Enriches data volume for software learning and provides clinical validation.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Hera - Mi competitors and assessment

Company assessment

Direct peers

  • Lunit: South Korea-based publicly listed AI company with Lunit INSIGHT MMG, a mammography AI solution directly comparable to Breast-SlimView in clinical decision support for breast cancer detection. Direct competitor in breast imaging AI across EU, MENA, and Asia.
  • Therapixel: French competitor specializing in MammoScreen, an AI-based mammography decision-support tool with CE mark and FDA clearance. Headquartered in France, Therapixel competes most directly with Hera-MI on geography, product, and breast imaging AI category.
  • Volpara Health: New Zealand-based breast imaging analytics company offering breast density assessment, mammography reporting, and cancer risk evaluation software. Highly comparable product/clinical positioning in breast imaging AI.
  • ScreenPoint Medical: Netherlands-based developer of Transpara, an AI breast imaging decision-support software for 2D/3D mammography with CE mark and FDA clearance. Direct competitor serving the same radiologist and breast center customers.
  • iCAD: US-based company offering ProFound AI for breast cancer detection and breast density assessment (PowerDensity), both FDA-cleared. Direct competitor in mammography AI, particularly relevant for Hera-MI's pending US entry.

Emerging players

  • DeepHealth (RadNet subsidiary): AI mammography company (Saige-Dx) acquired by RadNet, offering FDA-cleared AI for breast cancer detection and risk prediction. Emerging direct competitor with a strong US distribution backbone via RadNet's imaging centers.
  • Densitas: Canada-based company focused on breast density AI and mammography quality analytics, with comparable features to Hera-MI's MTE and breast density evaluation modules. Overlaps at feature level though narrower in overall breadth.

Broad incumbents

  • Hologic: US-listed leader in mammography hardware (3Dimensions, Genius AI) and integrated screening workflows. Operates broadly across breast imaging; important OEM-style incumbent that any breast AI specialist must integrate with or compete against.
  • Siemens Healthineers: Global medtech incumbent offering mammography systems (Mammomat) and AI-Rad Companion, with broad radiology AI portfolio. Broad incumbent providing integrating opportunities and competitive threats to specialist breast AI vendors.

Others

  • Fujifilm Healthcare: Mammography equipment OEM that is both a channel partner and a comparable ecosystem player. Comparable in that it sits adjacent as a mammography hardware vendor with breast imaging AI integrations, including Hera-MI's Breast-SlimView.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Hera - Mi social profiles

Digital presence

Hera - Mi compliance and trust

Trust signal

Compliance2 records

Hera - Mi financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hera - Mi leadership team

Management profile

Number of profiles

Profiles9 records

Hera - Mi subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Hera - Mi funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hera - Mi M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hera - Mi

What does Hera - Mi do?

Hera-MI develops and licenses Breast-SlimView, a Class IIa CE-marked medical device software that provides clinical decision support for 2D and 3D mammography (tomosynthesis) interpretation. The software uses a patented 'negativation' AI algorithm that removes physiological breast elements and replaces them with artificial fat to present only suspicious areas to radiologists, complemented by image quality evaluation (MTE), breast density classification, risk scoring, and prior examination comparison. It is sold to radiology departments, breast imaging centers, and hospitals through direct enterprise sales, channel partners, and an OEM integration with Fujifilm mammography equipment.

Is Hera - Mi a public or private company?

Hera - Mi is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Hera - Mi founded?

Hera - Mi was founded in 2017. It employs 11 to 50 people.

Where is Hera - Mi based?

Hera - Mi is headquartered in Saint-herblain, France, in the Europe region.

How does Hera - Mi make money?

One revenue line is on record: breast-SlimView Software Licenses.

Who are Hera - Mi's main competitors?

Direct peers on record are Lunit, Therapixel, Volpara Health, ScreenPoint Medical and iCAD. Emerging players are DeepHealth (RadNet subsidiary) and Densitas. Broad incumbents are Hologic and Siemens Healthineers. Fujifilm Healthcare is listed as an others.

Does Hera - Mi have an API?

No public API is recorded for Hera - Mi.

What industry is Hera - Mi in?

Hera - Mi's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales